CD8A and breast cancer: Finally, we immunostained breast cancer tissue sections from a murine-derived syngeneic transplant model14 for the CTL marker CD8 and found the immunostaining data was in good agreement with our RNAseq CTL score (Supplementary Fig. 3E).